Modulation of VLA-4 and L-selectin expression on normal CD34+ cells during mobilization with G-CSF

We have evaluated the immunophenotype, functional activity and clonogenic potential of CD34+ cells from peripheral blood (PB) of normal donors before and after 4 and 6 days of G-CSF administration. The percentage and absolute number of CD34+ cells significantly increased at days 4 and 6 of G-CSF administration, compared to the steady-state level (P < 0.0001). two-colour fluorescence analysis showed, at days 4 and 6, a lower proportion of cd34+/c-kit+ compared to the steady-state level (P < 0.0001), but a similar expression of cd13, cd33, cd38, hla-dr and thy-1 antigens on cd34+ cells. The expression of adhesion molecules on CD34+ cells revealed a significant reduction of CD11a (P = 0.009), CD18, CD49d and CD62L (P < 0.0001) at days 4 and 6, compared to the baseline level. three-colour staining showed a reduction of the more immature compartment (34+/DR−/13−) and an increase of the more differentiated compartment (34+/DR+/13+). Downregulation of VLA-4 during mobilisation was seen almost exclusively on more committed cells (34+/13+); downregulation of CD62L, on the contrary, was observed on both early progenitors (34+/13−) and more committed cells (34+/13+). The expression of 34+/VLA-4+ decreased on both c-kit+ and c-kit− cells, while the expression of 34+/62L+ decreased on the c-kit+ cells only. In vivo administration of G-CSF reduced the adherence capacity of CD34+ cells to normal BM stroma; in vitro incubation with SCF or IL-3 enhanced the expression of CD49d on CD34+ cells, while GM-CSF reduced the expression of CD62L. SCF was the only cytokine able to induce a significant increase of CD34+ cell adherence to preformed stroma. Pre-incubation with the blocking β2 integrin monoclonal antibody caused a reduction of CD34+ cell adherence. In conclusion, the decrease of CD49d expression on mobilized CD34+ cells correlates with a poor adhesion to BM stroma; CD34+ cells incubated in vitro with SCF showed, conversely, a higher expression of CD49d and a greater adherence capacity on normal preformed stroma.

[1]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[2]  T. Papayannopoulou,et al.  Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  L. Stoolman Adhesion molecules controlling lymphocyte migration , 1989, Cell.

[4]  M. Socinski,et al.  GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR EXPANDS THE CIRCULATING HAEMOPOIETIC PROGENITOR CELL COMPARTMENT IN MAN , 1988, The Lancet.

[5]  R. Möhle,et al.  Differential expression of L-selectin, VLA-4, and LFA-1 on CD34+ progenitor cells from bone marrow and peripheral blood during G-CSF-enhanced recovery. , 1995, Experimental hematology.

[6]  H. Nakauchi,et al.  Expression and function of adhesion molecules on human hematopoietic stem cells: CD34+ LFA-1- cells are more primitive than CD34+ LFA-1+ cells. , 1992, Blood.

[7]  R. Hoffman,et al.  Human hematopoietic stem cell adherence to cytokines and matrix molecules. , 1992, The Journal of clinical investigation.

[8]  J. Banchereau,et al.  Distribution of surface-membrane molecules on bone marrow and cord blood CD34+ hematopoietic cells. , 1992, Experimental hematology.

[9]  F. Prósper,et al.  Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor. , 1996, Blood.

[10]  L. To,et al.  A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells. , 1994, Blood.

[11]  F. Lund-Johansen,et al.  Differential surface expression of cell adhesion molecules during granulocyte maturation , 1993, Journal of leukocyte biology.

[12]  H. Nomura,et al.  Reduced response to granulocyte colony-stimulating factor in W/Wv and Sl/Sld mice. , 1991, Leukemia.

[13]  J. Greenberger,et al.  Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma. , 1992, The Journal of clinical investigation.

[14]  David A. Williams,et al.  Fibronectin and VLA-4 in haematopoietic stem cell–microenvironment interactions , 1991, Nature.

[15]  H. Goldschmidt,et al.  Blood-derived autografts collected during granulocyte colony-stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cells. , 1995, Blood.

[16]  J. Villeval,et al.  Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. , 1988, Blood.

[17]  A. Fauser,et al.  Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord blood , 1978 .

[18]  C. Figdor,et al.  Induction of LFA-1 on pluripotent CD34+ bone marrow cells does not affect lineage commitment. , 1996, Blood.

[19]  T. Springer,et al.  Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins , 1991, Cell.

[20]  P. Lansdorp,et al.  Expression of Thy-1 on human hematopoietic progenitor cells , 1993, The Journal of experimental medicine.

[21]  I. Weissman,et al.  Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis , 1991, The Journal of experimental medicine.

[22]  H. Juneja,et al.  Vascular cell adhesion molecule-1 and VLA-4 are obligatory adhesion proteins in the heterotypic adherence between human leukemia/lymphoma cells and marrow stromal cells. , 1993, Experimental hematology.

[23]  H. Nakauchi,et al.  Expression and function of adhesion molecules on human hematopoietic stem cells: CD34+ LFA-1- cells are more primitive than CD34+ LFA-1+ cells. , 1992, Blood.

[24]  R. Möhle,et al.  Expression of adhesion molecules and c-kit on CD34+ hematopoietic progenitor cells: comparison of cytokine-mobilized blood stem cells with normal bone marrow and peripheral blood. , 1993, Journal of hematotherapy.

[25]  Peter M. Lansdorp,et al.  Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. , 1991, Blood.

[26]  C. Chabannon,et al.  Phenotypic, molecular, and functional characterization of human peripheral blood CD34+/THY1+ cells. , 1996, Blood.